Your browser doesn't support javascript.
loading
Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization.
Jit, Mark; Dang, Thi Thanh Huyen; Friberg, Ingrid; Hoang, Van Minh; Pham Huy, Tuan Kiet; Walker, Neff; Nguyen, Van Cuong; Tran, Nhu Duong; Toda, Kohei; Hutubessy, Raymond; Fox, Kimberley; Nguyen, Tran Hien.
Afiliação
  • Jit M; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; Modelling and Economics Unit, Public Health England, London, UK. Electronic address: mark.jit@phe.gov.uk.
  • Dang TT; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Friberg I; John Hopkins Bloomberg School of Public Health, John Hopkins University, Baltimore, MD, USA.
  • Hoang VM; Center for Health System Research, Hanoi Medical University, Hanoi, Vietnam.
  • Pham Huy TK; Center for Health System Research, Hanoi Medical University, Hanoi, Vietnam.
  • Walker N; John Hopkins Bloomberg School of Public Health, John Hopkins University, Baltimore, MD, USA.
  • Nguyen VC; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Tran ND; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
  • Toda K; World Health Organization Representative Office for Viet Nam, Hanoi, Vietnam.
  • Hutubessy R; World Health Organization, Geneva, Switzerland.
  • Fox K; World Health Organization Regional Office for the Western Pacific, Manila, Philippines.
  • Nguyen TH; National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Vaccine ; 33 Suppl 1: A233-9, 2015 May 07.
Article em En | MEDLINE | ID: mdl-25919167
ABSTRACT

INTRODUCTION:

Countries like Vietnam transitioning to middle-income status increasingly bear the cost of both existing and new vaccines. However, the impact and cost-effectiveness of the Expanded Programme on Immunization (EPI) as a whole has never been assessed on a country level.

METHODS:

Data on vaccine-preventable disease incidence and mortality from Vietnam's national surveillance was analysed to estimate the likely impact that vaccination in 1980-2010 may have had. Adjustment for under-reporting was made by examining trends in reported mumps incidence and in case-fatality risks for each disease. The same data were separately analysed using the Lives Saved Tool (LiST) to give an alternative estimate of impact. The financial cost of EPI in 1996-2010 was also estimated from the perspective of service provider.

RESULTS:

National surveillance data suggests that up to 5.7 million diseases cases and 26,000 deaths may have been prevented by EPI. Analysis using LiST suggests that even more deaths (370,000) may have been prevented by measles and pertussis vaccination alone. The cost-effectiveness of EPI is estimated to be around $1000-$27,000 per death prevented.

CONCLUSION:

Two separate approaches to assessing EPI impact in Vietnam give different quantitative results but a common

conclusion:

that EPI has made a substantial impact on mortality and represents good value for money.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis / Vacinação / Programas de Imunização Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis / Vacinação / Programas de Imunização Idioma: En Ano de publicação: 2015 Tipo de documento: Article